Skip to main content

Advertisement

Fig. 3 | Cancer Communications

Fig. 3

From: Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis

Fig. 3

Impact of MGC on OS. a In all stages (early and advanced) of gastric cancer. The 5-year OS rate was 56.6% for the entire study cohort. For the MGC and SGC groups, the 5-year OS rates were 48.1% and 58.7%, respectively (P = 0.013). b In the early stage. The 5-year OS rate was 91.2%. For the MGC and SGC groups, the 5-year OS rates were 83.3% and 91.8%, respectively (P = 0.852). c In the advanced stage. The 5-year OS rate was 49.4%. For the MGC and SGC groups, the 5-year OS rates were 43.0% and 51.1%, respectively (P = 0.036). d The 5-year OS rates of MGC patients who underwent total gastrectomy and distal gastrectomy were 45.4% and 61.5%, respectively (P = 0.114). MGC multiple gastric cancers, SGC solitary gastric cancers, OS overall survival

Back to article page